Imipridones for Gliomas
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2017/015608, filed Jan 30, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,116,771 | G Protein-Coupled Receptor (GPCR) Modulation by Imipridones In force · Medium confidence | Jazz Pharmaceuticals Ireland Limited | In force | Medium confidence | ||
| US 11,976,068 | 7-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-a]PYRIDO[3,4-e]PYRIMIDIN-5(1H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FOR THEIR USE IN THERAPY In force · High confidence | Jazz Pharmaceuticals Ireland Limited | In force | High confidence | ||
| US 10,172,862 | Imipridones for Gliomas In force · Medium confidence | Jazz Pharmaceuticals Ireland Limited | In force | Medium confidence | ||
| US 10,369,154 | Imipridones for Gliomas In force · Low confidence | Jazz Pharmaceuticals Ireland Limited | In force | Low confidence | ||
| US 10,946,022 | Imipridones for Gliomas In force · Medium confidence | Jazz Pharmaceuticals Ireland Limited | In force | Medium confidence | ||
| US 12,102,639 | Imipridones for Gliomas In force · Low confidence | Jazz Pharmaceuticals Ireland Limited | In force | Low confidence | ||
| Application 17/388,551 | G Protein-Coupled Receptor (GPCR) Modulation by Imipridones Abandoned Abandoned Feb 10, 2026 | Jazz Pharmaceuticals Ireland Limited | Abandoned | Abandoned Feb 10, 2026 | ||
| Application 18/759,200 | Impridones for Gliomas Pending Not granted | Jazz Pharmaceuticals Ireland Limited | Pending | Not granted | ||
| Application 18/979,567 | 7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e] PYRIMIDIN-5 (1 H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FOR THEIR USE IN THERAPY Pending Not granted | Jazz Pharmaceuticals Ireland Limited | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Jazz Pharmaceuticals, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.